<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Tue, 06 Jan 2026 16:09:23 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Beyond The Numbers: 7 Analysts Discuss Moelis Stock</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/49739319/beyond-the-numbers-7-analysts-discuss-moelis-stock</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Latest Ratings for MC Date Firm Action From To Mar 2022 Piper Sandler Maintains Overweight Mar 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Pip...</description><pubDate>Tue, 06 Jan 2026 21:01:45 GMT</pubDate></item><item><title>What 6 Analyst Ratings Have To Say About Avery Dennison</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/49739298/what-6-analyst-ratings-have-to-say-about-avery-dennison</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Latest Ratings for AVY Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 UBS Maintains Neutral Nov 2021 Raymond James Init...</description><pubDate>Tue, 06 Jan 2026 21:01:36 GMT</pubDate></item><item><title>Analyst Expectations For Evercore's Future</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/49739288/analyst-expectations-for-evercores-future</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Latest Ratings for EVR Date Firm Action From To Mar 2022 Piper Sandler Maintains Overweight Mar 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Go...</description><pubDate>Tue, 06 Jan 2026 21:01:24 GMT</pubDate></item><item><title>Where Alignment Healthcare Stands With Analysts</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/49739257/where-alignment-healthcare-stands-with-analysts</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Latest Ratings for ALHC Date Firm Action From To Mar 2022 Goldman Sachs Maintains Buy Mar 2022 Morgan Stanley Maintains Overweight Mar 2022 Cowen &amp; Co...</description><pubDate>Tue, 06 Jan 2026 21:01:13 GMT</pubDate></item><item><title>What 5 Analyst Ratings Have To Say About Houlihan Lokey</title><link>https://www.benzinga.com/insights/analyst-ratings/26/01/49739239/what-5-analyst-ratings-have-to-say-about-houlihan-lokey</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Latest Ratings for HLI Date Firm Action From To Mar 2022 Piper Sandler Maintains Neutral Mar 2022 Morgan Stanley Maintains Underweight Feb 2022 Morgan...</description><pubDate>Tue, 06 Jan 2026 21:00:56 GMT</pubDate></item></channel></rss>